Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.

June 27, 2018   |   June 2018 Bond Updates
ZUG, Switzerland, June 27, 2018 /PRNewswire/ -- Drug developer Berlin Cures today announced the formation of a Business Advisory Board (BAB) and the appointment of its first two members, Dr. Ulf Berg and Dr. Dragan Grabulovski. The BAB's role will be to provide ongoing counsel, along with...

View more at: https://www.prnewswire.com/news-releases/berlin-cures-strengthens-business-advisory-board-with-the-appointments-of-ulf-berg-phd-and-dragan-grabulovski-phd-300672687.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/